Navigation Links
Hologic And Gen-Probe Provide Update On Pending Transaction
Date:7/11/2012

ders for Dimensions systems that were placed, but not shipped, during the third quarter of fiscal 2012. Hologic expects the majority of these orders to be installed in the fourth quarter of fiscal 2012. The customer site readiness requirements for tomosynthesis are more extensive than for the 2D systems and therefore the accelerated shift from 2D to 3D mammography orders has contributed to an initial delay in installations. Consequently, backlog of orders was stronger at the end of the third quarter than at the end of the second quarter.

Hologic noted that sales of its Dimensions 3D breast tomosynthesis system are exceeding expectations. As a result, Hologic noted the following key items:

  • Backlog and bookings for 3D mammography systems significantly increased as of June 23, 2012 as compared to March 24, 2012;
  • Hologic has reached over 45% of its two-year unit goal of 500 to 700 3D systems in the U.S. and, with units already in backlog, will meet the target of 60% of this range by the end of fiscal 2012.
  • Hologic's fiscal third quarter non-GAAP adjusted EPS is expected to meet or exceed the guidance of $0.34 provided on April 30, 2012 as a result of favorable product mix and disciplined expense management.

    The preliminary financial information presented in this news release represents estimates only, as Hologic has not completed its financial statements for its third quarter ended June 23, 2012 and its independent auditor has not commenced its review thereof. Actual results, therefore, may differ materially from those estimated. At this preliminary stage, Hologic does not have the financial data available to estimate its GAAP earnings. GAAP EPS may be affected by changes in ongoing assumptions and judgments relating to Hologic's acquired businesses and may also be affected by nonrecurring, unusual or unanticipated charges, expenses or gains (including expenses related to the Gen-Probe acquisition), all of which are excluded in
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Hologic, Inc. Announces Note Offering
    2. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
    3. Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
    4. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
    5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
    6. Gen-Probe Withdraws from Previously Announced Investor Presentations
    7. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
    8. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
    9. TPI Provides Further Updates on its GMOL Flagship Product
    10. PatientPay from Zepherella Now Offers Real-time Pricing, Automatic Payment Reconciliation for Healthcare Providers and Patients
    11. Providers of Durable Medical Equipment Ensure Independence and Safety during Extreme Weather and Power Outages
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
    (Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
    (Date:8/27/2015)... Aug. 27, 2015 DURECT Corporation (Nasdaq: ... present at three upcoming healthcare conferences.  ... will present at the Rodman & Renshaw Investment Conference ... The conference is being held at the St. Regis ... A live audio webcast of the presentation will be ...
    Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
    ... Simulation Corporation (MSC) is proud to offer innovative, guideline-based ... through the Health Care Innovation Challenge, announced on November ... Services. Simulation provides a unique, risk-free environment ... in managing patients with diagnoses associated with high mortality ...
    ... International Corporation (NASDAQ: PRXL ), a leading ... been selected as one of two strategic partners by ... services worldwide. PAREXEL will work with UCB ... to increase productivity and cost effectiveness. The ...
    Cached Medicine Technology:Medical Simulation Corporation Offers Innovative Training Solutions for Healthcare Organizations Applying to the Department of Health and Human Services' Health Care Innovation Challenge 2UCB and PAREXEL Sign Strategic Partnership Agreement 2UCB and PAREXEL Sign Strategic Partnership Agreement 3UCB and PAREXEL Sign Strategic Partnership Agreement 4
    (Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
    (Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President Chris Bustamante ... Vice President of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado ... its reach and impact through innovative technologies and strategies. , “I am very proud ...
    (Date:8/29/2015)... ... 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of ... will present an educational program titled “Asbestos and Your Health.” , The two and ... open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA ...
    (Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
    (Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day weekend, the last ... on September 22nd this year). For IT security personnel, it should also mark the ... prove far more costly than a simple headache. , Joe Caruso, founder and CEO-CTO ...
    Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
    ... Exhibiting people evidence of the harm unhealthy habits do can ... of studies on biomarkers indicators of health or disease ... people's behaviour. ,They learned that if you reveal ... smoking it does encourage people to quit for fear ...
    ... percent of people, usually in middle age. People with the ... It is not the type of arthritis common in the ... the immune system goes awry and attacks the joints, causing ... stiffness. It is also linked to an increased risk of ...
    ... of a catastrophic conditions in organ transplant patients, Doctor's ... develop hardened arteries, a condition// called arteriosclerosis, in the ... team from the Maryland's Women's Hospital, USA, found ... during a year-long study. Dr James Fang, who led ...
    ... Alzheimer's is a degenerative brain disease that usually ... events or familiar tasks. The disease eventually leads// ... judgment. Communication becomes more difficult as the disease ... finish thoughts or follow directions. Eventually, most people ...
    ... Research suggests that anxiety during pregnancy can increase a ... indicated that women who were very anxious// in the ... behavioural problems. ,Lead researcher Professor Vivette Glover, ... to women who had extreme anxiety, and were frequently ...
    ... to Dr. John Poll, curing a laborious birth defect that ... sliced apart all the bones of her face but didn't ... a promising alternative to grueling bone grafts: Poll attached a ... each day with a screwdriver, slowly pulling out the sunken ...
    Cached Medicine News:Health News:Surgery-Rigged pulley helps patients 2
    For the quantitative in vitro determination of creatinine in serum, plasma or urine....
    The TBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of total bilirubin in serum and plasma...
    The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
    Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
    Medicine Products: